Works matching DE "NON-small-cell lung carcinoma"
Results: 5000
Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells.
- Published in:
- Cancer Biology & Medicine, 2025, v. 22, n. 1, p. 48, doi. 10.20892/j.issn.2095-3941.2024.0459
- By:
- Publication type:
- Article
Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
- Published in:
- Cancer Biology & Medicine, 2025, v. 22, n. 1, p. 21, doi. 10.20892/j.issn.2095-3941.2024.0456
- By:
- Publication type:
- Article
A clinical model to predict brain metastases in resected early-stage non-small cell lung cancer.
- Published in:
- BMC Cancer, 2025, v. 24, p. 1, doi. 10.1186/s12885-025-13609-y
- By:
- Publication type:
- Article
Comparative analysis of VMAT plans on Halcyon and infinity for lung cancer radiotherapy.
- Published in:
- PLoS ONE, 2025, v. 20, n. 2, p. 1, doi. 10.1371/journal.pone.0318462
- By:
- Publication type:
- Article
The role of BIM gene deletion in ALK-mutated Non-small cell lung cancer treated with alectinib.
- Published in:
- Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01579-1
- By:
- Publication type:
- Article
LncRNA MSTO2P affects the proliferation, invasion and migration of non-small cell lung cancer by regulating the Wnt/β-catenin pathway.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01920-w
- By:
- Publication type:
- Article
High barriers to treatment are associated with stereotactic radiation instead of surgery for patients with operable stage I non-small cell lung cancer†.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2025, v. 67, n. 1, p. 1, doi. 10.1093/ejcts/ezae450
- By:
- Publication type:
- Article
MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2025, v. 20, n. 2, p. 1, doi. 10.1371/journal.pone.0316716
- By:
- Publication type:
- Article
Role of dasatinib in the management of lung cancer: A meta-analysis of clinical trials.
- Published in:
- Biomedical Reports, 2025, v. 22, n. 3, p. N.PAG, doi. 10.3892/br.2025.1929
- By:
- Publication type:
- Article
Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18618
- By:
- Publication type:
- Article
Navigating the complexity of BRAF mutations in non-small cell lung cancer: current insights and future prospects.
- Published in:
- Multidisciplinary Respiratory Medicine, 2024, v. 19, p. 1, doi. 10.5826/mrm.2024.992
- By:
- Publication type:
- Article
Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1400422
- By:
- Publication type:
- Article
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13614-1
- By:
- Publication type:
- Article
Impact of coronary artery disease on outcomes of video-assisted thoracoscopic surgery for non-small cell lung cancer: A retrospective analysis.
- Published in:
- Laparoscopic Endoscopic Surgical Science, 2024, v. 31, n. 4, p. 185, doi. 10.14744/less.2024.62144
- By:
- Publication type:
- Article
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: A network meta‑analysis.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2025.14903
- By:
- Publication type:
- Article
Characteristics of genomic alterations and heavy metals in hypertensive patients with non‑small cell lung cancer.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2025.14898
- By:
- Publication type:
- Article
Prognostic value of upper paratracheal lymph node resection in stage IB right‑sided lung cancer: A retrospective cohort study.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2025.14883
- By:
- Publication type:
- Article
RNA analysis of patients with benign and malignant pulmonary nodules.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2025.14878
- By:
- Publication type:
- Article
Diverse clinical outcomes for the EGFR‑mutated and ALK‑rearranged advanced non‑squamous non‑small cell lung cancer.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2025.14872
- By:
- Publication type:
- Article
CircENTPD7 affects the immune escape of non‑small cell lung cancer cells by modulating the IGF2BP2/PD‑L1 axis.
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14858
- By:
- Publication type:
- Article
Patients with non‑small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review).
- Published in:
- Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14855
- By:
- Publication type:
- Article
Screening of multi deep learning-based de novo molecular generation models and their application for specific target molecular generation.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-86840-z
- By:
- Publication type:
- Article
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-80301-9
- By:
- Publication type:
- Article
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1533556
- By:
- Publication type:
- Article
Rare skin adverse reactions induced by osimertinib: a case report and literature review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1523541
- By:
- Publication type:
- Article
Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Comparing survival outcomes of localized tumor destruction, sublobar resection, and pulmonary lobectomy in stage IA non-small cell lung cancer: a study from the SEER database.
- Published in:
- European Journal of Medical Research, 2025, v. 30, n. 1, p. 1, doi. 10.1186/s40001-025-02325-9
- By:
- Publication type:
- Article
Massively parallel variant-to-function mapping determines functional regulatory variants of non-small cell lung cancer.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56725-w
- By:
- Publication type:
- Article
Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability.
- Published in:
- Cell & Bioscience, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13578-025-01358-1
- By:
- Publication type:
- Article
Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer.
- Published in:
- Insights into Imaging, 2025, v. 16, n. 1, p. 1, doi. 10.1186/s13244-025-01910-0
- By:
- Publication type:
- Article
Indications, contributing factors, and short-term outcomes of pneumonectomy: an 8-year retrospective study in a resource-limited setting.
- Published in:
- Journal of Cardiothoracic Surgery, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13019-024-03268-8
- By:
- Publication type:
- Article
The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07621-y
- By:
- Publication type:
- Article
The Treatment Effect of Plantago Major on Lung Cancer Based on the Computed Tomography and Pathological Findings: A Case Report Study.
- Published in:
- Frontiers in Biomedical Technologies, 2025, v. 12, n. 1, p. 161, doi. 10.18502/fbt.v12i1.17744
- By:
- Publication type:
- Article
Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer.
- Published in:
- BMC Pulmonary Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12890-025-03509-z
- By:
- Publication type:
- Article
Multimodal lung cancer theranostics via manganese phosphate/quercetin particle.
- Published in:
- Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02242-9
- By:
- Publication type:
- Article
Retraction: Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer.
- Published in:
- Clinical Science, 2025, v. 139, n. 2, p. 213, doi. 10.1042/CS20190519_RET
- Publication type:
- Article
Pembrolizumab plus Pemetrexed and Platinum in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Real-Life Study at a Portuguese Centre.
- Published in:
- Acta Médica Portuguesa, 2025, v. 38, n. 2, p. 99, doi. 10.20344/amp.22126
- By:
- Publication type:
- Article
Non-cancerous CT findings as predictors of survival outcome in advanced non-small cell lung cancer patients treated with first-generation EGFR-TKIs.
- Published in:
- PLoS ONE, 2025, v. 20, n. 2, p. 1, doi. 10.1371/journal.pone.0313577
- By:
- Publication type:
- Article
Development and validation of a predictive model for lymph node metastases in peripheral non-small cell lung cancer with a tumor diameter ≤ 2.0 cm and a consolidation-to-tumor ratio > 0.5.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1436771
- By:
- Publication type:
- Article
Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1503262
- By:
- Publication type:
- Article
Editorial: Insights in clinical and translational physiology: 2023.
- Published in:
- Frontiers in Physiology, 2025, p. 1, doi. 10.3389/fphys.2025.1508102
- By:
- Publication type:
- Article
PHOSPHORYLASE KINASE REGULATORY SUBUNIT ALPHA 1 AS A NOVEL BIOMARKER INVOLVED IN DEVELOPMENT AND PROGRESSION OF LUNG CANCER: COMPREHENSIVE BIOINFORMATIC ANALYSIS AND EXPERIMENT VALIDATION.
- Published in:
- Journal of Physiology & Pharmacology, 2024, v. 75, n. 6, p. 775, doi. 10.26402/jpp.2024.6.08
- By:
- Publication type:
- Article
Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1523743
- By:
- Publication type:
- Article
Nomogram prediction model for overall survival of late-stage lung cancer patients undergoing iodine-125 particle implantation brachytherapy.
- Published in:
- Journal of Contemporary Brachytherapy, 2024, v. 16, n. 6, p. 1, doi. 10.5114/jcb.2024.146836
- Publication type:
- Article
Effect of SBRT plus immunotherapy on immune status and survival quality of NSCLC patients: A study of combined radiotherapy and immunotherapy.
- Published in:
- Technology & Health Care, 2025, v. 33, n. 1, p. 485, doi. 10.3233/THC-241177
- By:
- Publication type:
- Article
Validation of endoplasmic reticulum stress-related gene signature to predict prognosis and immune landscape of patients with non-small cell lung cancer.
- Published in:
- Technology & Health Care, 2025, v. 33, n. 1, p. 363, doi. 10.3233/THC-241059
- By:
- Publication type:
- Article
Baseline 18F FDG PET/CT imaging in NSCLC: Possible utility in predicting strong-positive PD-L1 expression.
- Published in:
- Acibadem Saglik Bilimleri Dergisi, 2025, v. 16, n. 1, p. 164, doi. 10.31067/acusaglik.1549756
- By:
- Publication type:
- Article
The Association of Plasma Asymmetric Dimethylarginine Concentrations and Inflammation Markers in Non-small Cell Lung Cancer.
- Published in:
- Medical Bulletin of Sisli Etfal Hospital, 2024, v. 58, n. 4, p. 460, doi. 10.14744/SEMB.2024.29939
- By:
- Publication type:
- Article
Study on Cantharidin Reversing the Drug-resistance of Non-small Cell Lung Cancer to DDP by Regulating the Expression of PD-L1.
- Published in:
- Pharmacognosy Magazine, 2025, v. 21, n. 1, p. 74, doi. 10.1177/09731296241262832
- By:
- Publication type:
- Article
"ALKanthocytes".
- Published in:
- Annales de Biologie Clinique, 2024, v. 82, n. 6, p. 661, doi. 10.1684/abc.2024.1929
- By:
- Publication type:
- Article